trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['bcsm', 'breast', 't-dxd']
t-dxd for patients with her2-low metastatic breast cancer: patient-reported outcomes #esmo22 #bcsm #breastcancer #immunotherapy #oncology
News and views from the world of clinical oncology and hematology